Share This Article:

Use of a naturally occurring codon bias for identifying topoisomerase mutations in ciprofloxacin resistant Escherichia coli using PCR and future prospects with other bacterial genera: A pilot study

Abstract Full-Text HTML Download Download as PDF (Size:659KB) PP. 366-371
DOI: 10.4236/abc.2012.24045    3,326 Downloads   5,663 Views   Citations

ABSTRACT

We developed a novel PCR method aimed at identi- fying and amplifying native codon sequences of muta- tion-prone amino acids in DNA gyrase implicated in quinolone resistance using a naturally occurring co- don bias in E. coli DNA gyrase A.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Krishnan, S. , Balasubramanian, D. , Raju, B. and Lakshmi, B. (2012) Use of a naturally occurring codon bias for identifying topoisomerase mutations in ciprofloxacin resistant Escherichia coli using PCR and future prospects with other bacterial genera: A pilot study. Advances in Biological Chemistry, 2, 366-371. doi: 10.4236/abc.2012.24045.

References

[1] Reece, R.J. and Maxwell, A. (1991) DNA gyrase: Structure and function. Critical Reviews in Biochemistry and Molecular Biology, 26, 335-375. doi:10.3109/10409239109114072
[2] Collin, F., Karkare, S. and Maxwell, A. (2011) Exploiting bacterial DNA gyrase as a drug target: Current state and perspectives. Applied Microbiology and Biotechnology, 67, 479-497. doi:10.1007/s00253-011-3557-z
[3] Baker, N.M., Weigand, S., Maar-Mathias, S. and Mondragon, A. (2011) Solution structures of DNA-bound gyrase. Nucleic Acids Research, 39, 755-766. doi:10.1093/nar/gkq799
[4] Oppegaard, H. and Sorum, H. (1996) Cloning and nucleotide sequence of the DNA gyrase gyrA gene from the fish pathogen Aeromonas salmonicida. Antimicrobial Agents and Chemotherapy, 40, 1126-1133.
[5] Ruiz, J. (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. Journal of Antimicrobial Chemotherapy, 51, 1109-1117. doi:10.1093/jac/dkg222
[6] Gruger, T., Nitiss, J.L., Maxwell, A., Zechiedrich, E.L., Heisig, P., Seeber, S., Pommier, Y. and Strumberg, D. (2004) A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II. Antimicrobial Agents and Chemotherapy, 48, 4495-4504. doi:10.1128/AAC.48.12.4495-4504.2004
[7] Barnard, F.M. and Maxwell, A. (2001) Interaction between DNA gyrase and quinolones: Effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87). Antimicrobial Agents and Chemotherapy, 45, 1994-2000. doi:10.1128/AAC.45.7.1994-2000.2001
[8] Diaz-Lazcoz, Y., Henaut, A., Vigier, P. and Risler, J.L. (1995) Differential codon usage for conserved amino acids: Evidence that the serine codons TCN were primordial. Journal of Molecular Biology, 250, 123-127. doi:10.1006/jmbi.1995.0363
[9] Kahali, S., Sarkar, B., Rajendran, K., Khanam, J., Yamasaki, S., Nandy, R.K., Bhattacharya, S.K. and Rama- murthy, T. (2004) Virulence characteristics and molecular epidemiology of enteroaggregative Escherichia coli isolates from hospitalized diarrheal patients in Kolkata, India. Journal of Clinical Microbiology, 42, 4111-4120. doi:10.1128/JCM.42.9.4111-4120.2004
[10] Subramanian, K., Selvakkumar, C., Vinaykumar, K.S., Goswami, N., Meenakshisundaram, S., Balakrishnan, A. and Lakshmi, B.S. (2009) Tackling multiple antibiotic resistance in enteropathogenic Escherichia coli (EPEC) clinical isolates: A diarylheptanoid from Alpinia office-narum shows promising antibacterial and immunomodulatory activity against EPEC and its lipopolysaccharide-induced inflammation. International Journal of Antimicrobial Agents, 33, 244-250. doi:10.1016/j.ijantimicag.2008.08.032
[11] Cattoir, V., Poirel, L., Rotimi, V., Soussy, C.J. and Nordmann, P. (2007) Multiplex PCR for detection of plasmidmediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. Journal of Antimicrobial Chemotherapy, 60, 394-397. doi:10.1093/jac/dkm204
[12] Qiang, Y.Z., Qin, T., Fu, W., Cheng, W.P., Li, Y.S. and Yi, G. (2002) Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli. Journal of Antimicrobial Chemotherapy, 49, 549-552. doi:10.1093/jac/49.3.549
[13] Cesaro, A., Bettoni, R.R., Lascols, C., Merens, A., Soussy, C.J. and Cambau, E. (2008) Low selection of to- poisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes. Journal of Antimi-crobial Chemotherapy, 61, 1007-1015. doi:10.1093/jac/dkn077
[14] Pandey, M., Khan, A., Das, S.C., Sarkar, B., Kahali, S., Chakraborty, S., Chattopadhyay, S., Yamasaki, S., Takeda, Y., Nair, G.B. and Ramamurthy, T. (2003) Association of cytolethal distending toxin locus cdtB with enteropatho-genic Escherichia coli isolated from patients with acute diarrhea in Calcutta, India. Journal of Clinical Microbiology, 41, 5277-5281. doi:10.1128/JCM.41.11.5277-5281.2003
[15] Karlin, S., Mrazek, J. and Campbell, A.M. (1998) Codon usages in different gene classes of the Escherichia coli genome. Molecular Microbiology, 29, 1341-1355. doi:10.1046/j.1365-2958.1998.01008.x
[16] Madurga, S., Sanchez-Cespedes, J., Belda, I., Vila, J. and Giralt, E. (2008) Mechanism of binding of fluoroqui-nolones to the quinolone resistance-determining region of DNA gyrase: Towards an understanding of the molecular basis of quinolone resistance. Chembiochem, 9, 2081- 2086. doi:10.1002/cbic.200800041

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.